Article Text

PDF
▾ More ace inhibitors – quinapril, perindopril & ramipril

Abstract

During 1990 quinapril (Accupro – Parke-Davis), perindopril (Coversyl – Servier) and ramipril (Tritace – Hoechst) joined captopril, enalapril and lisinopril1, 2 as inhibitors of angiotensin-converting enzyme (ACE) for the treatment of hypertension. Of the newer drugs only quinapril is currently licensed for use in heart failure. Claims, such as ‘a unique pharmacokinetic profile’ for quinapril, and of ‘high performance’ for perindopril, and the promotional emphasis on evidence that perindopril reverses hypertensive structural change in arteries, need critical examination.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.